Withaferin A Inhibits Nuclear Factor- B-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  Martorana, Francesca ^a   Guidotti, Giulia ^a   Brambilla, Liliana ^a   Rossi, Daniela ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; WITHAFERIN A; ANTINEOPLASTIC AGENT; LIPOPOLYSACCHARIDE; NFKB1 PROTEIN, HUMAN; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; WITHANOLIDE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYMATIC ASSAY; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; ENCEPHALITIS; GENETICS; HUMAN; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPINAL CORD; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTROCYTES; CELL LINE, TUMOR; CYCLOOXYGENASE 2; ENCEPHALITIS; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE II; SIGNAL TRANSDUCTION; SPINAL CORD; STRESS, PSYCHOLOGICAL; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; WITHANOLIDES;

EID: 84938635604     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/381964     Document Type: Article

References (46)

1. C. Farina, F. Aloisi, and E. Meinl, "Astrocytes are active players in cerebral innate immunity" Trends in Immunology, vol. 28, no. 3, pp. 138-145, 2007.
2. R. M. Ransohoff and M. A. Brown, "Innate immunity in the central nervous system" The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1164-1171, 2012.
3. D. Rossi, "Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death" Progress in Neurobiology, vol. 130, pp. 86-120, 2015.
4. L. Brambilla, F. Martorana, and D. Rossi, "Astrocyte signaling and neurodegeneration: new insights into CNS disorders" Prion, vol. 7, no. 1, pp. 28-36, 2013.
5. Q. Zhang, R. Kang, H. J. Zeh III, M. T. Lotze, and D. Tang, "DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death" Autophagy, vol. 9, no. 4, pp. 451-458, 2013.
6. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, andF. H. Gage, "Mechanisms underlying inflammation in neurodegeneration" Cell, vol. 140, no. 6, pp. 918-934, 2010.
7. M. Bsibsi, R. Ravid, D. Gveric, and J. M. van Noort, "Broad expression of Toll-like receptors in the human central nervous system" The Journal of Neuropathology and Experimental Neurology, vol. 61, no. 11, pp. 1013-1021, 2002.
8. C. C. Bowman, A. Rasley, S. L. Tranguch, and I. Marriott, "Cultured astrocytes express toll-like receptors for bacterial products" Glia, vol. 43, no. 3, pp. 281-291, 2003.
9. P. A. Carpentier, W. S. Begolka, J. K. Olson, A. Elhofy, W. J. Karpus, and S. D. Miller, "Differential activation of astrocytes by innate and adaptive immune stimuli" Glia, vol. 49, no. 3, pp. 360-374, 2005.
10. M. Bsibsi, C. Persoon-Deen, R. W. H. Verwer, S. Meeuwsen, R. Ravid, and J. M. Van Noort, "Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators" Glia, vol. 53, no. 7, pp. 688-695, 2006.
11. K. Hoshino, O. Takeuchi, T. Kawai et al. , "Cutting edge: tolllike receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product" Journal of Immunology, vol. 162, no. 7, pp. 3749-3752, 1999.
12. A. Poltorak, X. He, I. Smirnova et al. , "Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene" Science, vol. 282, no. 5396, pp. 2085-2088, 1998.
13. S. T. Qureshi, L. Lariviére, G. Leveque et al. , "Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4)" The Journal of Experimental Medicine, vol. 189, no. 4, pp. 615-625, 1999.
14. R. Gorina, M. Font-Nieves, L. Márquez-Kisinousky, T. Santalucia, and A. M. Planas, "Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways" Glia, vol. 59, no. 2, pp. 242-255, 2011.
15. H. L. Pahl, "Activators and target genes of Rel/NF-κB transcription factors" Oncogene, vol. 18, no. 49, pp. 6853-6866, 1999.
16. D. Singh, A. Aggarwal, R. Maurya, and S. Naik, "Withania somnifera inhibitsNF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells" Phytotherapy Research, vol. 21, no. 10, pp. 905-913, 2007.
17. M. Kaileh, W. Vanden Berghe, A. Heyerick et al. , "Withaferin A strongly elicits IκB kinase β hyperphosphorylation concomitant with potent inhibition of its kinase activity" Journal of Biological Chemistry, vol. 282, no. 7, pp. 4253-4264, 2007.
18. A. Grover, A. Shandilya, A. Punetha, V. S. Bisaria, and D. Sundar, "Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-kappaB activation suppression by Withania somniferas key metabolite withaferin A" BMC Genomics, vol. 11, no. 4, article S25, 2010.
19. V. Khedgikar, P. Kushwaha, J. Gautam et al. , "Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone" Cell Death and Disease, vol. 4, no. 8, article e778, 2013.
20. R. Maitra, M. A. Porter, S. Huang, andB. P. Gilmour, "Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation" Journal of Inflammation, vol. 6, article 15, 2009.
21. B. C. McFarland, S. W. Hong, R. Rajbhandari et al. , "NF-κBinduced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma" PLoS ONE, vol. 8, no. 11, Article ID e78728, 2013.
22. J. Lee, E.-R. Hahm, and S. V. Singh, "Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells" Carcinogenesis, vol. 31, no. 11, pp. 1991-1998, 2010.
23. K.-J. Min, K. Choi, and T. K. Kwon, "Withaferin A downregulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells" International Immunopharmacology, vol. 11, no. 8, pp. 1137-1142, 2011.
24. H. J. Um, K.-J. Min, D. E. Kim, and T. K. Kwon, "Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells" Biochemical and Biophysical Research Communications, vol. 427, no. 1, pp. 24-29, 2012.
25. P. S. Frisa, M. N. Goodman, G. M. Smith, J. Silver, and J. W. Jacobberger, "Immortalization of immature and mature mouse astrocytes with SV40 T antigen" Journal of Neuroscience Research, vol. 39, no. 1, pp. 47-56, 1994.
26. F. Martorana, L. Brambilla, C. F. Valori et al. , "The BH4 domain of Bcl-X L rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals" Human Molecular Genetics, vol. 21, no. 4, pp. 826-840, 2012.
27. D. Rossi, L. Brambilla, C. F. Valori et al. , "Focal degeneration of astrocytes in amyotrophic lateral sclerosis" Cell Death and Differentiation, vol. 15, no. 11, pp. 1691-1700, 2008.
28. L. Gautron, P. Lafon, M. Chaigniau, G. Tramu, and S. Layé, "Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge" Neuroscience, vol. 112, no. 3, pp. 717-729, 2002.
29. Y. Nakano, E. Furube, S. Morita, A. Wanaka, T. Nakashima, and S. Miyata, "Astrocytic TLR4 expression and LPS-induced nuclear translocation of STAT3 in the sensory circumventricular organs of adult mouse brain" Journal of Neuroimmunology, vol. 278, pp. 144-158, 2015.
30. E. Beurel and R. S. Jope, "Lipopolysaccharide-induced interleukin-3 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain" Journal of Neuroinflammation, vol. 6, article 9, 2009.
31. Y.-J. Lee, D.-Y. Choi, I. S. Choi et al. , "Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2, 4-bis(p-hydroxyphenyl)-2-butenal on amyloid-beta generation and inflammatory reactions via inhibition of NF-kappaB and STAT3 activation in cultured astrocytes and microglial BV-2 cells" Journal of Neuroinflammation, vol. 8, article 132, 2011.
32. X. Liu, Y. Tian, N. Lu, T. Gin, C. H. K. Cheng, and M. T. V. Chan, "Stat3 inhibition attenuates mechanical allodynia through transcriptional regulation of chemokine expression in spinal astrocytes" PLoS ONE, vol. 8, no. 10, Article ID e75804, 2013.
33. D. V. Kuprash, I. A. Udalova, R. L. Turetskaya, D. Kwiatkowski, N. R. Rice, and S. A. Nedospasov, "Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide" Journal of Immunology, vol. 162, no. 7, pp. 4045-4052, 1999.
34. Y. Kim and S. M. Fischer, "Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues" Journal of Biological Chemistry, vol. 273, no. 42, pp. 27686-27694, 1998.
35. S. T. Reddy, D. J. Wadleigh, and H. R. Herschman, "Transcriptional regulation of the cyclooxygenase-2 gene in activatedmast cells" The Journal of Biological Chemistry, vol. 275, no. 5, pp. 3107-3113, 2000.
36. Q.-W. Xie, R. Whisnant, andC. Nathan, "Promoter of themouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide" The Journal of Experimental Medicine, vol. 177, no. 6, pp. 1779-1784, 1993.
37. M. T. Heneka, D. T. Golenbock, and E. Latz, "Innate immunity in Alzheimers disease" Nature Immunology, vol. 16, no. 3, pp. 229-236, 2015.
38. T. Philips and W. Robberecht, "Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation inmotor neuron disease" The Lancet Neurology, vol. 10, no. 3, pp. 253-263, 2011.
39. P. Bezzi, G. Carmignoto, L. Pasti et al. , "Prostaglandins stimulate calcium-dependent glutamate release in astrocytes" Nature, vol. 391, no. 6664, pp. 281-285, 1998.
40. P. Bezzi, M. Domercq, L. Brambilla et al. , "CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity" Nature Neuroscience, vol. 4, no. 7, pp. 702-710, 2001.
41. V. L. Dawson, T. M. Dawson, E. D. London, D. S. Bredt, and S. H. Snyder, "Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, " Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 14, pp. 63686371, 1991.
42. S. R. Parathath, S. Parathath, and S. E. Tsirka, "Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice" Journal of Cell Science, vol. 119, no. 2, pp. 339-349, 2006.
43. R. Brambilla, V. Bracchi-Ricard, W.-H. Hu et al. , "Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury" The Journal of Experimental Medicine, vol. 202, no. 1, pp. 145-156, 2005.
44. R. Brambilla, T. Persaud, X. Hu et al. , "Transgenic inhibition of astroglial NF-κB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous systeminflammation" Journal of Immunology, vol. 182, no. 5, pp. 2628-2640, 2009.
45. E. S. Fu, Y. P. Zhang, J. Sagen et al. , "Transgenic inhibition of glial NF-κ B reduces pain behavior and inflammation after peripheral nerve injury" Pain, vol. 148, no. 3, pp. 509-518, 2010.
46. R. Brambilla, G. Dvoriantchikova, D. Barakat, D. Ivanov, J. R. Bethea, and V. I. Shestopalov, "Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis" Journal of Neuroinflammation, vol. 9, article 213, 2012.